These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28684305)

  • 21. Mast Cells in Neurodegenerative Disease.
    Jones MK; Nair A; Gupta M
    Front Cell Neurosci; 2019; 13():171. PubMed ID: 31133804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways.
    Zeng KW; Wang S; Dong X; Jiang Y; Tu PF
    Phytomedicine; 2014 Feb; 21(3):298-306. PubMed ID: 24055519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of neuroinflammation in neurodegenerative diseases (Review).
    Chen WW; Zhang X; Huang WJ
    Mol Med Rep; 2016 Apr; 13(4):3391-6. PubMed ID: 26935478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.
    Mammana S; Fagone P; Cavalli E; Basile MS; Petralia MC; Nicoletti F; Bramanti P; Mazzon E
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases.
    Guo S; Wang H; Yin Y
    Front Aging Neurosci; 2022; 14():815347. PubMed ID: 35250543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
    Peña-Altamira E; Prati F; Massenzio F; Virgili M; Contestabile A; Bolognesi ML; Monti B
    Expert Opin Ther Targets; 2016; 20(5):627-40. PubMed ID: 26568363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system.
    Toft-Hansen H; Babcock AA; Millward JM; Owens T
    J Neuroinflammation; 2007 Sep; 4():24. PubMed ID: 17883829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A research update on the potential roles of aquaporin 4 in neuroinflammation.
    Lan YL; Fang DY; Zhao J; Ma TH; Li S
    Acta Neurol Belg; 2016 Jun; 116(2):127-34. PubMed ID: 26259614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomaterials and glia: Progress on designs to modulate neuroinflammation.
    Tsui C; Koss K; Churchward MA; Todd KG
    Acta Biomater; 2019 Jan; 83():13-28. PubMed ID: 30414483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes.
    Yang R; Yang B; Liu W; Tan C; Chen H; Wang X
    J Neuroinflammation; 2023 Jul; 20(1):173. PubMed ID: 37481642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.
    Russo C; Valle MS; Russo A; Malaguarnera L
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases.
    Krahn AI; Wells C; Drewry DH; Beitel LK; Durcan TM; Axtman AD
    ACS Chem Neurosci; 2020 Jul; 11(13):1871-1886. PubMed ID: 32464049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases.
    Song GJ; Suk K
    Front Aging Neurosci; 2017; 9():139. PubMed ID: 28555105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Microglia TLRs in Neurodegeneration.
    Fiebich BL; Batista CRA; Saliba SW; Yousif NM; de Oliveira ACP
    Front Cell Neurosci; 2018; 12():329. PubMed ID: 30333729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
    Langenfurth A; Rinnenthal JL; Vinnakota K; Prinz V; Carlo AS; Stadelmann C; Siffrin V; Peaschke S; Endres M; Heppner F; Glass R; Wolf SA; Kettenmann H
    J Neurosci Res; 2014 Mar; 92(3):275-86. PubMed ID: 24323769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrotic Scar in Neurodegenerative Diseases.
    D'Ambrosi N; Apolloni S
    Front Immunol; 2020; 11():1394. PubMed ID: 32922384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase: Bridging the gap in neurodegeneration.
    Ray RS; Katyal A
    Neurosci Biobehav Rev; 2016 Sep; 68():611-620. PubMed ID: 27343997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transglutaminase 2 and neuroinflammation.
    Ientile R; Currò M; Caccamo D
    Amino Acids; 2015 Jan; 47(1):19-26. PubMed ID: 25398223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases.
    Takeuchi H; Suzumura A
    Front Cell Neurosci; 2014; 8():189. PubMed ID: 25228858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.